tweetindex
PT

S Blitshteyn MD, FAAN, FANA, Dysautonomia Clinic

@dysclinic · Buffalo, NY · joined 24 Jul 2019

Neurologist/Researcher, Director of #Dysautonomia Clinic, Clinical Associate Professor @Jacobs_Med_UB. Trained @MayoClinic. Tweets🚫med advice. Opinions my own.

22 787Followers
1 704Following
8 504Posts total
162.4KViews on collected posts

Posts recentes

We reviewed the topic of IVIG and other immunomodulating therapies in patients with #POTS and #LongCOVID. The bottom line it CAN be very effective, but rigid clinical trial protocols may be a barrier to replicating its benefits observed in clinical practice. 4.1K views · 79 likes · 19 reposts · 2 replies Open on X →
Lazzaro Spallanzani IRCCS studied 1 man with severe Long COVID. High-dose IVIG was followed by recovery and fewer CD8 T cell–monocyte complexes, IFNγ, endothelial inflammation and GPCR autoantibodies. Causality is unproven. https://t.co/f3pwhxLNXo 6.1K views · 57 likes · 13 reposts · 2 replies Open on X →
This is not an uncommon physical exam finding in my clinic. Med students love it! 👁️👀 2.4K views · 8 likes · 0 reposts · 1 replies Open on X →
When it looks scary, but it's benign https://t.co/BuPpjmZzIN @NEJM Adie Tonic Pupil https://t.co/ks1Hu5yKBa
32.7K views · 42 likes · 12 reposts · 5 replies Open on X →
Mornings are traditionally viewed as the time when #POTS and #dysautonomia symptoms are at their worst compared to afternoon or evening. Could this be due to prothrombotic state in addition to poor hydration after sleep? 6.8K views · 159 likes · 25 reposts · 13 replies Open on X →
A cautionary tale about waiting for biomarkers first and therapeutics second. As always, I keep referring to my headache medicine colleagues who figured out that, despite a lack of a biomarker for migraine, therapeutics can still be developed and FDA-approved. 🧠💉 3.8K views · 97 likes · 9 reposts · 3 replies Open on X →
Key Point 4 from the second Editor's Pick Circadian Neurology by Dr. Sabra M. Abbott from the August #SleepNeurology issue, which is open to all at https://t.co/cXPvAh2v2a https://t.co/d72eFb25hW
8.2K views · 25 likes · 6 reposts · 0 replies Open on X →
I am incredibly honored to have been invited to talk about #LongCovid and #Dysautonomia by the brilliant @EricTopol on his Ground Truths podcast. It's amazing to achieve this despite all of the obstacles in my life. 🙏🧠👩‍🔬 @Jacobs_Med_UB @AANmember @DrABrashear #BrainHealth 98.2K views · 466 likes · 86 reposts · 46 replies Open on X →

Em comparação com contas do mesmo porte

7 posts dos últimos 90 dias, ao lado da faixa de 10K–100K seguidores. aparece para muita gente, mas poucos desses espectadores reagem.

Mediana de visualizações6 102esta conta954mediana para 10K–100K
Alcance, %26.78%esta conta3.32%mediana para 10K–100K
Engajamento, %1.21%esta conta1.87%mediana para 10K–100K
MétricaEsta contaMediana para 10K–100KProporção
Mediana de visualizações por post6 1029546.40×
Alcance (visualizações ÷ seguidores)26.78%3.32%8.07×
Taxa de engajamento1.21%1.87%0.65×

Outras contas desta faixa →   Comparar com outra conta →   Como estas referências são construídas →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

98.2K20 May
8.2K4 Sep
3.8K5 Sep
6.8K6 Sep
32.7K
2.4K
6.1K8 Sep
4.1K9 Sep

Last 8 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

0.62%20 May
0.39%4 Sep
2.83%5 Sep
2.91%6 Sep
0.18%
0.37%
1.21%8 Sep
2.41%9 Sep

Reactions — likes, reposts, replies and quotes — divided by views. Median for 10K–100K accounts is 1.87%.

What the audience does

Likes66.1%933 in total
Reposts12.0%170 in total
Replies5.1%72 in total
Quotes0.8%11 in total
Bookmarks15.9%225 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

The follower curve appears once this account has two daily snapshots — we take one a day, and this one is on its first.

Contas semelhantes